Shandong Boan Biotechnology Balance Sheet Health
Financial Health criteria checks 3/6
Shandong Boan Biotechnology has a total shareholder equity of CN¥1.4B and total debt of CN¥654.2M, which brings its debt-to-equity ratio to 47%. Its total assets and total liabilities are CN¥2.5B and CN¥1.2B respectively. Shandong Boan Biotechnology's EBIT is CN¥19.8M making its interest coverage ratio 1. It has cash and short-term investments of CN¥172.1M.
Key information
47.0%
Debt to equity ratio
CN¥654.23m
Debt
| Interest coverage ratio | 1x |
| Cash | CN¥172.12m |
| Equity | CN¥1.39b |
| Total liabilities | CN¥1.16b |
| Total assets | CN¥2.55b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 6955's short term assets (CN¥749.0M) exceed its short term liabilities (CN¥555.6M).
Long Term Liabilities: 6955's short term assets (CN¥749.0M) exceed its long term liabilities (CN¥601.0M).
Debt to Equity History and Analysis
Debt Level: 6955's net debt to equity ratio (34.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 6955's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 6955's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 6955's interest payments on its debt are not well covered by EBIT (1x coverage).